Ptc Therapeutics reported $14.01M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
TG Therapeutics TGTX:US USD 2K 21K
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Amgen AMGN:US USD 1.59B 78M
Biocryst Pharmaceuticals BCRX:US USD 3.61M 3.37M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Daiichi Sankyo 4568:JP JPY 84.77B 9.97B
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Gilead Sciences GILD:US USD 1.4B 47M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
IONIS PHARMACEUT IONS:US USD 1.52M 3.23M
Karyopharm Therapeutics KPTI:US USD 980K 41K
Novartis NOVN:VX USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Roche Holding ROG:VX 9.56B 717M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M
YTE INCY:US USD 49.28M 4.05M